As one of the first European countries joining the Stent for Life initiative - with a low ratio of primary PCI, in comparison to its European neighbours, and a lack of awareness among the population - Portugal is today pointed as a European example in the implementation of the Stent-Save a Life! initiative. Learn how Portugal has significantly improved the level of healthcare provided to AMI patients and their access to an appropriate treatment.
26 results found for: STEMI
Well known for its record-breaking long distance runners, perhaps less well known for its increased prevalence of heart attacks, discover the challenges faced by Kenya in providing optimal for STEMI patients throughout the country.
Guidelines present relevant evidence to help physicians weigh the benefits and risks of a particular diagnostic or therapeutic procedure. They should be essential in everyday clinical decision making.
ST-segment elevation myocardial infarction (STEMI)
ST-Elevation Myocardial Infarction (STEMI) is a very serious type of heart attack during which one of the heart’s major arteries is blocked.
- Acute Myocardial Infarction in patients presenting with ST-segment elevation (Management of)
Ph. Gabriel Steg (Chairperson), Stefan K. James (Chairperson), Dan Atar, Luigi P. Badano, Carina Blomström Lundqvist, Michael A. Borger, Carlo Di Mario, Kenneth Dickstein, Gregory Ducrocq, Francisco Fernandez-Aviles, Anthony H. Gershlick, Pantaleo Giannuzzi, Sigrun Halvorsen, Kurt Huber, Peter Juni, Adnan Kastrati, Juhani Knuuti, Mattie J. Lenzen, Kenneth W. Mahaffey,Marco Valgimigli, Arnoud van’t Hof, Petr Widimsky, Doron Zahger.
European Heart Journal 2012;33:2569-2619 – doi:10.1093/eurheartj/ehs215.
Guidelines
NSTEMI (Non-ST-segment elevation myocardial infarction)
Non-ST Segment Elevation Myocardial Infarction (NSTEMI) is one of the three types of Acute Coronary Syndrome (ACS), and like all ACS, NSTEMI should be considered a medical emergency.
- Acute Coronary Syndromes (ACS) in patients presenting without persistent ST-segment elevation (Management of)
Christian W. Hamm (Chairperson) (Germany), Jean-Pierre Bassand (Co-Chairperson) (France), Stefan Agewall (Norway), Jeroen Bax (The Netherlands), Eric Boersma (The Netherlands), Hector Bueno (Spain), Pio Caso (Italy), Dariusz Dudek (Poland), Stephan Gielen (Germany), Kurt Huber (Austria), Magnus Ohman (USA), Mark C. Petrie (UK), Frank Sonntag (Germany), Miguel Sousa Uva (Portugal), Robert F. Storey (UK), William Wijns (Belgium), Doron Zahger (Israel).
European Heart Journal (2011)32, 2999–3054 – doi:10.1093/eurheartj/ehr236
Guidelines
Stents and scaffolds, PCI and Myocardial revascularization
Myocardial revascularization, or laser revascularization, is an alternative procedure for patients with ischemic heart disease who are unable to get percutaneous coronary intervention or coronary artery bypass graft procedures because of procedure failure, diffuse coronary artery disease, small coronary arteries, etc. This topic will present studies of coronary artery stent types including DES with bioresorbable vascular scaffolds and more.
- Myocardial Revascularisation (Guidelines for)
William Wijns FESC (Chairperson), Philippe Kolh FESC (Chairperson), Nicolas Danchin FESC, Carlo Di Mario FESC, Volkmar Falk, Thierry Folliguet, Scot Garg, Kurt Hubert, Stefan James FESC, Juhani Knuuti FESC, Jose Lopez-Sendon, Jean Marco FESC, Lorenzo Menicanti, Miodrag Ostojic FESC, Massimo F. Piepoli FESC, Charles Pirlet, Jose L. Pomar, Nicolaus Reifart FESC, Flavio L. Ribichini, Martin J. Schalij FESC, Paul Sergeant, Patrick W. Serruys FESC,Sigmund Silber FESC, Miguel Sousa Uva FESC, David Taggart .
European Heart Journal (31):2051-2555 – doi:10.1093/eurheartj/ehq277
Guidelines
Acute Myocardial Infarction (AMI)
Myocardial infarction (MI) or acute myocardial infarction (AMI), commonly known as a heart attack, occurs when blood flow stops to a part of the heart causing damage to the heart muscle. The most common symptom is chest pain or discomfort which may travel into the shoulder, arm, back, neck, or jaw.
- Universal definition of myocardial infarction.
Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction.
Circulation. 2007 Nov 27;116(22):2634–53 – doi:10.1093/eurheartj/ehm355
Guidelines
- Third Universal Definition of Myocardial Infarction
Kristian Thygesen, Joseph S. Alpert, Allan S. Jaffe, Maarten L. Simoons,Bernard R. Chaitman and Harvey D. White; Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction.
European Heart Journal (2012) 33, 2551–2567 – doi:10.1093/eurheartj/ehs184
Guidelines
During the first year, we determined the main barriers that exist in the management of STEMI patients in our country. The most significant barrier is our health system that is organized around three main providers, which is highly fragmented with a low integration between parties. In this context, we decided to choose a model formed by private or public centers with the objective of developing door-to-balloon programs in each one. Learn more...
Christoph Kurt Naber, Germany
Director, Department of Cardiology and Angiology, Contilia
Heart and Vascular Center Elisabeth-Krankenhaus, Essen
During the seven years of Stent for Life Initiative’s existence, the SFL Mission has remained the same:
Reduce the mortality and morbidity of patients suffering from acute coronary syndromes (ACS) by supporting the implementation of European Clinical Practice Guidelines on Myocardial Revascularization at national and regional levels.
We have accomplished a lot – today patients from 21 countries in Europe, Asia, Africa and South America benefit from SFL programs. In partnership with hospitals, payers, governments and industry partners, SFL helps to create healthcare models that can deliver more efficient and improved care to ACS patients while maintaining or reducing costs.
We are pleased to announce that Dr. Christoph K. Naber has been appointed Stent for Life Initiative Chairman for the years 2016 – 2018. Dr. Naber is an active member of the PCR family. He is the course-co-director of EuroPCR and PCR London Valves, and course-director of AsiaPCR. He has served as a member of the executive board of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology (ESC), and is a member of the editorial boards of EuroIntervention and AsiaIntervention. Dr. Christoph Naber is a past-chairman of the German Working Group of Interventional Cardiology (AGIK/DGK).
We are very proud that the SFL activities’ impact on healthcare can be validated by clinical and economic evidence. To measure the SFL’s impact on STEMI patients’ access to PPCI, the third in a row Stent for Life ACS market survey will be initiated this year under the leadership of Christoph K. Naber. The ESC member and affiliate member countries will be invited to collect data on reperfusion treatment by using a self-administered questionnaire, and provide descriptive analysis of the type of reperfusion utilization, time delays, pharmacotherapy and medical device use at a national level.
Join us in wishing Christoph K. Naber all the best and much success in leading the Stent for Life Initiative!
In 2016, the Belarusian Scientific Society of Cardiologists and the Belarusian Society of Endovascular Surgery and Interventional Cardiology have initiated the process of joining the European initiative Stent Save a Life. The goal – to improve the quality of interventional care for patients with acute coronary syndrome (ACS) and the use of best European practices in our daily work.
